Stereochemical Issues in Chiral Drug Development |
Choi, Sun-Ok
(Division of Biopharmaceutics, Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration)
Jung, Sung-Hee (Division of Biopharmaceutics, Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration) Um, So-Young (Division of Biopharmaceutics, Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration) Jung, Seo-Jeong (Division of Biopharmaceutics, Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration) Kim, Joo-Il (Division of Biopharmaceutics, Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration) Chung, Soo-Youn (Division of Biopharmaceutics, Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration) |
1 | Guidance for Industry : Stereochemical Issues in Chiral Drug Development. Therapeutic Products Programme, Health Canada (2000. 5. 1.) |
2 | B.-C. Sallustio and R.-G. Morris, High-performance liquid chromatographic determination of sotalol in plasma, J. Chromatogr., 576, 321-327 (1992) DOI ScienceOn |
3 | B.-A. Persson, K. Balmer and P.-O. Langerstorm, Enantioselective determination of metoprolol in plasma by liquid chromatography on a silica-bonded -acid glycoprotein column, J. Chromatogr., 500, 629-636 (1990) DOI ScienceOn |
4 | J. Ducharme, C. Fernandez, F. Gimenez and R. Farinotti, Critical issues in chiral drug analysis in biological fluids by high-performance liquid chromatography, J. Chromatogr. B., 686, 65-75 (1996) DOI ScienceOn |
5 | G. Subramanian, A practical approach to chiral separations by liquid chromatography, 62 (1994) |
6 | Guidance for Industry : FDA'S Policy Statement For The Development Of New Stereoisomeric Drugs. CDER, US FDA (1992. 5. 1.) |
7 | Q6A International Conference on Harmonisation ; Guidance on Q6A Specifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products : Chemical Substances (2000) |